Skip to content
Tuesday, November 10, 2026
Block Club Chicago delivers hyperlocal news, events coverag…

Administering Stem Cells During Pregnancy to Infants with Spina Bifida Enhances Life Outcomes, Trial Finds

A groundbreaking clinical study has found that administering stem cells to developing infants diagnosed with spina bifida as part of a surgical repair could constitute a "major milestone" in addressing congenital conditions.

Research Framework and Assurance

The research conducted in the United States focused on six developing infants with the 'open' form of spina bifida. Doctors administered regenerative cells sourced from the maternal placenta on the exposed area of the baby's spinal cord while the defect was being closed.

Importantly, the regenerative treatment was found to be safe. The study team reported that the cells did not cause neoplasms, hinder surgical recovery, or block the correction of associated brain abnormalities.

Encouraging Results

Magnetic resonance imaging performed on the newborns confirmed a complete reversal of hindbrain herniation in every participant. This brain structure normalization is strongly associated with enhanced physical outcomes.

"If it makes additional babies able to walk who otherwise would not, it could establish itself as their standard of care," commented the principal investigator. "The outcomes appear extremely promising and pave the way for a variety of prospective new treatments."

Future Implications and Hope

Experts not involved in the trial proposed that further confirmation of these observed advantages could herald a "new era" in prenatal intervention. The prospect of enhancing nerve function impairment present before birth is viewed as a paradigm-shifting aim.

Especially significant would be improvements in bladder and bowel function, which are common challenges for those diagnosed with this disorder.

Future Directions

Although this preliminary study focused on a handful of cases, its established security and encouraging indicators offer a robust platform for broader investigative efforts. The integration of stem cell therapy with proven prenatal surgical methods holds considerable promise for improving the prognosis for infants diagnosed prenatally with spina bifida.

Written by

Taylor Frost

Maya Rodriguez is a Chicago-based journalist passionate about urban development and community activism, with a focus on local stories that impact daily life.

Block Club Chicago

Type to search articles.